As Basheer and colleagues demonstrated, the role of EZH2 is very context-dependent, with it being either a tumor suppressor or an oncogene depending on the stage of disease and depending on which of its targets are being manipulated by its activity[13]. This evidence concerns the gene EZH2 and neoplasm.